All In Biotech

Drug Trial Radar · NCT01656538

A Study of Reolysin For Patients With Advanced/Metastatic Breast Cancer

A Randomized Phase II Study of Reolysin For Patients Receiving Standard Weekly Paclitaxel Therapy as Therapy For Advanced/Metastatic Breast Cancer

Last checked: Nov 19, 2026Latest source record: Aug 4, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

81

Actual

Start

Feb 20, 2013

Primary completion

Nov 18, 2016

Study completion Feb 14, 2018

Sponsor

Lead sponsor
Canadian Cancer Trials GroupResearch network
Sponsor type
Research network
Collaborators
Oncolytics Biotech
First posted
Aug 3, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Researchers doing this study want to evaluate the side effects of Reolysin when given together with paclitaxel. As these drugs have not been given together before, 6-9 patients will be treated with paclitaxel plus reolysin to ensure that side effects are tolerable.

Conditions

  • Metastatic Breast Cancer

Interventions

  • PaclitaxelDrug

  • ReolysinDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression free survivalTime frame: 24 months

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • BCCA - Cancer Centre for the Southern Interior

    Kelowna, British Columbia, Canada

  • BCCA - Vancouver Cancer Centre

    Vancouver, British Columbia, Canada

  • BCCA - Vancouver Island Cancer Centre

    Victoria, British Columbia, Canada

  • Juravinski Cancer Centre at Hamilton Health Sciences

    Hamilton, Ontario, Canada

  • Cancer Centre of Southeastern Ontario at Kingston

    Kingston, Ontario, Canada

  • Ottawa Hospital Research Institute

    Ottawa, Ontario, Canada

  • Allan Blair Cancer Centre

    Regina, Saskatchewan, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.